The global biological seed treatment market is estimated to be valued at USD 0.9 billion in 2020 and is projected to reach USD 1.7 billion by 2025, recording a CAGR of 11.9%.The market is influenced by the adoption of sustainable agricultural practices, along with strong investments being made by major market players in the research and development of these products. The agricultural and environmental benefits associated with these biological seed treatment solutions are the major factors contributing to the growth of this market globally. Beneficial microorganisms and plant extracts are projected to act as important tools that could help reduce the usage of synthetic fertilizers and chemical pesticides, thereby reducing the investments by farmers and environmental risks.
Download PDF Brochure @
Driver: Environmental concerns associated with chemical seed treatment
The demand for biological seed treatment has significantly increased as a result of high awareness of their potential and the growing attention to the environmental and health risks associated with conventional chemicals. Chemical seed treatments are detrimental to the environment and pose a serious risk to pollinators. The neonicotinoid class of insecticides is considered highly toxic to honeybees. Microorganisms employed as active substances in pest management are recognized as generally safe for the environment and non-target species, in comparison with synthetic chemicals.
By crop type, the soybean segment is projected to be the fastest-growing segment in the seed treatment market during the forecast period.
The soybean crop requires significant exposure to nitrogen for growth and development, which can be supplied through biological fixation by seed inoculants. Hence, the market for biological seed treatment in soybean is projected to grow at the fastest rate during the forecast period. Bio-nematicide seed treatments help protect the roots from soybean cyst nematode (SCN) feeding by parasitizing the nematode, inhibiting nerve transmission, or creating a protective barrier around the roots to repel nematodes.
By type, the microbials segment is projected to dominate the seed treatment market during the forecast period.
The biological seed treatment market, by type, has been segmented into microbials, botanicals, and others (biofermentation products and natural polymers derivatives). The microbials industry dominated the market in 2020, due to the increasing demand for microbial seed treatments, in field crops such as soybean and corn.
Many key companies, such as Bayer AG (Germany), Syngenta Group (Switzerland), and Corteva Agriscience (US), offer innovative biological seed treatment solutions for controlling seed and soil-borne diseases in a broad range of crops. This exponential growth in this North America region is attributed to government subsidies, increasing need to improve and protect food production, and rising awareness of biological seed treatment.
Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=162422288
North America is projected to be the fastest-growing market
The major reason for the biological seed treatment market experiencing such a high growth rate is the highly streamlined product registration process, which makes it easier for most private companies to launch their products easily. Lower investment requirements and limited gestation period involved in the development and commercialization of biological products are key factors attracting a large number of startup companies in the industry. Additionally, growing awareness among consumers against synthetic chemicals has also led to higher adoption of these products.
This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. It also includes the profiles of leading companies such as BASF SE (Germany), Bayer AG (Germany), Syngenta Group(Switzerland), Corteva Agriscience (US), Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert Biological Systems (Netherlands), Italpollina (Italy), Marrone Bio Innovation (US), Certis Europe (Netherlands), UPL Limited (India), Novozymes A/S (Denmark), IPL Biologicals (India), Rizobacter (Argentina), Bioworks, Inc (US), Advanced Biological Marketing (US), Kan Biosys (India), and Incotec (Netherlands).